Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Pluri Stock Price, Quotes and Forecasts | NASDAQ:PLUR | Benzinga
Explore Pluri stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PLUR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pluri (PLUR) stock?
You can purchase shares of Pluri (NASDAQ:PLUR) through any online brokerage.
Who are Pluri (PLUR) competitors?
Other companies in Pluri’s space includes: Intensity Therapeutics (NASDAQ:INTS), Burning Rock Biotech (NASDAQ:BNR), Aligos Therapeutics (NASDAQ:ALGS), FibroGen (NASDAQ:FGEN) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for Pluri (PLUR) stock?
There is no analysis for Pluri to provide a consensus price target.
What is the current price for Pluri (PLUR)?
The stock price for Pluri (NASDAQ: PLUR) is $3.76 last updated April 15, 2025 at 1:15 PM EDT.
Does Pluri (PLUR) pay a dividend?
There are no upcoming dividends for Pluri.
When is Pluri (NASDAQ:PLUR) reporting earnings?
Pluri’s Q3 earnings are confirmed for Friday, May 9, 2025.
Is Pluri (PLUR) going to split?
There is no upcoming split for Pluri.
What sector and industry does Pluri (PLUR) operate in?
Pluri is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.